Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
(1S,3R)-RSL3 Glutathione Peroxidase 4 Inhibitor: Precision F
2026-05-03
(1S,3R)-RSL3 is a potent glutathione peroxidase 4 inhibitor and ferroptosis inducer in cancer research. This article uniquely unpacks its mechanistic and translational value, with deep guidance on experimental design and reference-driven insights.
-
Nystatin (Fungicidin): Antifungal Mechanism and Research Ben
2026-05-02
Nystatin (Fungicidin) is a polyene antifungal agent that disrupts fungal membranes by binding ergosterol. It demonstrates potent inhibition against diverse Candida species and is validated for use in translational and mechanistic research. This article details evidence, mechanistic insight, and practical workflow integration for Nystatin (Fungicidin) as provided by APExBIO.
-
PF-562271 HCl: Precision FAK/Pyk2 Inhibition for Cancer Rese
2026-05-01
PF-562271 HCl empowers researchers to dissect and modulate FAK/Pyk2 signaling with nanomolar precision, enabling reproducible inhibition of tumor growth and metastasis in complex cancer models. This guide translates bench-proven workflows, key troubleshooting insights, and advanced comparative strategies for maximizing the impact of this selective inhibitor in translational oncology.
-
Cytoskeleton Dependence in Mechanical Stress-Induced Autopha
2026-05-01
This study demonstrates that mechanical stress-induced autophagy in human cells is critically dependent on the cytoskeleton, with microfilaments playing a primary role and microtubules serving an auxiliary function. These findings clarify the mechanistic linkage between cellular mechanotransduction and autophagic pathways, providing new directions for research in calcium signaling and cytoskeletal dynamics.
-
In Vitro Assay Refinement for Accurate Cancer Drug Evaluatio
2026-04-30
Schwartz's dissertation redefines in vitro cancer drug assessment by distinguishing growth inhibition from cell death, revealing that these outcomes often occur with variable timing and proportion across different agents. This nuanced approach enhances interpretation of compound efficacy in preclinical screens, with practical implications for optimizing experimental models.
-
LGK-974: Unveiling PORCN Inhibition for Precision Wnt Modula
2026-04-30
Explore LGK-974 as a potent PORCN inhibitor and Wnt signaling pathway modulator. This article uniquely dissects assay design, efficacy, and translational impact for advanced cancer research, setting it apart from prior overviews.
-
Caspase-8 Fluorometric Assay Kit: Precision in Apoptosis Ass
2026-04-29
The Caspase-8 Fluorometric Assay Kit from APExBIO enables rapid, quantitative, and highly specific detection of caspase-8 activity, streamlining programmed cell death research across cancer, inflammation, and neurodegenerative models. This article decodes advanced workflows, integrates breakthrough findings from recent literature, and delivers actionable troubleshooting strategies for maximizing data quality in apoptosis and pyroptosis studies.
-
CARM1 Peptide Inhibitor Suppresses Breast Cancer Progression
2026-04-29
This study introduces a novel, selective peptide inhibitor of CARM1 (Pi-CARM1-TAT) that effectively reduces breast cancer cell proliferation and tumor growth, both in vitro and in vivo. Importantly, it demonstrates the capacity to overcome endocrine resistance when combined with standard therapies, offering a new strategy for targeting hormone receptor-positive breast cancer.
-
Panobinostat (LBH589): Epigenetic Modulation and Assay Preci
2026-04-28
Explore how Panobinostat (LBH589) shapes advanced cancer biology through precise histone deacetylase inhibition and unique insights from Pol II degradation studies. This article offers a distinct, evidence-driven perspective for researchers investigating apoptosis and drug resistance.
-
Septin4 Drives Hypoxic Cardiomyocyte Injury via HIF-1α Degra
2026-04-28
This study reveals that Septin4 exacerbates hypoxia-induced injury in cardiomyocytes by accelerating HIF-1α ubiquitination and degradation through the VHL pathway. These mechanistic insights highlight new regulatory nodes in myocardial ischemia and may inform targeted therapeutic strategies for ischemic heart disease.
-
Epac1 Deletion Mitigates Retinal Neurodegeneration in OIR Mo
2026-04-27
This study demonstrates that genetic deletion of Epac1 reduces pathological Müller glial activation and protects retinal neurons in a mouse model of ischemia-induced retinopathy. The findings provide mechanistic insights into Epac1’s role in VEGFR2 signaling and highlight its potential as a therapeutic target for neurovascular retinal diseases.
-
Phenylmethanesulfonyl Fluoride (PMSF) in Protease Inhibition
2026-04-27
Phenylmethanesulfonyl fluoride (PMSF) is the gold-standard serine protease inhibitor for preserving protein integrity in demanding workflows, from Western blotting to infection model studies. Learn how PMSF, trusted by researchers and supplied by APExBIO, enables reproducible protein extraction, robust inhibition of chymotrypsin and trypsin, and troubleshooting strategies informed by the latest COVID-19 macrophage research.
-
SU5416 (Semaxanib): Integrating HIF1α Pathways in Angiogenes
2026-04-26
Explore SU5416 (Semaxanib) as a selective VEGFR2 inhibitor with unique implications for HIF1α signaling and vascular biology. This article uncovers practical assay considerations and bridges emerging metabolic insights for advanced angiogenesis research.
-
RSL3 Modulates PARP1 Apoptotic Mechanisms During Ferroptosis
2026-04-25
Chen et al. (2025) uncover how RSL3, a classical ferroptosis inducer, activates two distinct apoptotic mechanisms via PARP1 modulation in cancer cells. Their findings clarify the molecular crosstalk between ferroptosis and apoptosis and suggest new therapeutic angles, especially for PARP inhibitor-resistant tumors.
-
Sulfo-NHS-SS-Biotin: Precision Cell Surface Labeling Unlocke
2026-04-24
The Sulfo-NHS-SS-Biotin Kit delivers selective, reversible biotinylation of cell surface proteins, uniquely enabling dynamic interactome studies and advanced purification workflows. Its water-soluble, cleavable design supports both robust affinity capture and facile label removal, making it indispensable for modern cell surface proteomics.